Evidence map›Paper›PMID 40802698›Full record

ArticlePloS one2025

SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE).

Jorge L Martinez-Cajas, Beatriz Alvarado, Ann Jolly, Yanping Gong, Bradley Stoner, Gerald Evans, Santiago Perez-Patrigeon, T Hugh Guan

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jorge L Martinez-CajasDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Beatriz AlvaradoDepartment of Public Health Sciences. Queen's University, Kingston, Ontario, Canada.ORCID 0000-0002-1269-405X
Ann JollyDepartment of Public Health Sciences. Queen's University, Kingston, Ontario, Canada.
Yanping GongDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Bradley StonerDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0000-0003-4713-5271
Gerald EvansDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.ORCID 0000-0003-2557-0897
Santiago Perez-PatrigeonDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
T Hugh GuanDivision of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe established a longitudinal cohort of healthcare workers (HCWs) in an acute care hospital (ACH) and four long-term care homes (LTCHs) in Ontario, Canada, to follow the incidence of SARS-CoV-2 infection, humoral immune response to infection and/or vaccination, and determinants of infection risk. Here, we 1) describe the cohort regarding the distribution of main exposures, outcomes and serologic assays, 2) describe the unadjusted incidence of SARS-CoV-2 infection risk in the overall population, and 3) summarize the analysis and its pertinence. METHODS AND

participantsHCWs were recruited between November 24, 2020, and July 24, 2021. They completed a baseline survey, monthly surveillance for 9-12 months, a post-Omicron-wave survey, and provided blood samples for anti-SARS-CoV-2 antibody measurements. We collected data on host-related (humoral response to vaccines and SARS-CoV-2 infection) and environmental factors (social contact history and occupational, household and community conditions). Descriptive analysis by setting, comparison of distributions, and unadjusted survival analysis were performed.

resultsIn total, 143 HCWs from the ACH and 57 from LTCHs had complete data, and 72% were followed until September 2022. Nearly 60% of the sample consisted of nurses, nurse assistants and personal support workers. Survival analysis showed that the risk of infection was bimodal, with low risk throughout the study period until the first Omicron wave. ACH HCWs had a higher risk of infection during the Omicron waves than during the preceding waves (Odds Ratio = 7.64; CI95%: 4.24-13.7), while LTCH HCWs at high-risk facilities experienced a similar risk of infection before and during the Omicron waves (OR = 1.76; CI95%: 0.63-4.9). During the Omicron waves, the use of protective equipment by HCWs working with institutional COVID-19 cases increased, but the use of community protective measures diminished. Household infections reported by participating HCWs also increased during the Omicron waves compared to previous waves. Immunoglobulin G (IgG) antibody levels increased over two time periods, (Pre vs Post- Omicron) likely due to the immune response to high levels of both vaccination and SARS-CoV-2 infections. DISCUSSION: We observed a low incidence of COVID-19 until the onset of the Omicron waves, which highlights the drastic impact of this Variants of Concern (VOC) on transmission and the importance of infectious agent characteristics. Our analysis indicated a ninefold increased risk of infection compared to that in earlier pandemic periods. Further analysis will allow the estimation of 1) the risk factors for SARS-CoV-2 infection at the community, household and healthcare facility levels, 2) the relationship between humoral responses and SARS-CoV-2 infection/vaccination, and 3) the role of social contact in work, household and community settings in the risk of infection.

Indexed as

COVID-19Health PersonnelAdultAntibodies, ViralFemaleHumansIncidenceLongitudinal StudiesLong-Term CareMaleMiddle AgedOccupational ExposureOntarioRisk FactorsSARS-CoV-2Antibodies, Viral

Identifiers

PMID40802698
PMCPMC12349196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.